Molecular mechanisms and animal models of spinal muscular atrophy

被引:34
|
作者
Edens, Brittany M. [1 ]
Ajroud-Driss, Senda [2 ]
Ma, Long [3 ]
Ma, Yong-Chao [1 ]
机构
[1] Northwestern Univ, Lurie Childrens Hosp, Chicago Res Ctr, Feinberg Sch Med,Dept Pediat,Dept Neurol & Physio, Chicago, IL 60611 USA
[2] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[3] Cent S Univ, State Key Lab Med Genet, Changsha 410078, Hunan, Peoples R China
关键词
SMA; SMN; Animal disease models; C; elegans; Drosophila; Zebrafish; SURVIVAL-MOTOR-NEURON; AMYOTROPHIC-LATERAL-SCLEROSIS; INCREASES SMN EXPRESSION; VALPROIC ACID INCREASES; MOUSE MODEL; MESSENGER-RNA; DROSOPHILA-MELANOGASTER; NEUROMUSCULAR-JUNCTION; SPLICING DEFECTS; DETERMINING GENE;
D O I
10.1016/j.bbadis.2014.07.024
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Spinal muscular atrophy (SMA), the leading genetic cause of infant mortality, is characterized by the degeneration of spinal motor neurons and muscle atrophy. Although the genetic cause of SMA has been mapped to the Survival Motor Neuron1 (SMN1) gene, mechanisms underlying selective motor neuron degeneration in SMA remain largely unknown. Here we review the latest developments and our current understanding of the molecular mechanisms underlying SMA pathogenesis, focusing on the animal model systems that have been developed, as well as new diagnostic and treatment strategies that have been identified using these model systems. This article is part of a special issue entitled: Neuromuscular Diseases: Pathology and Molecular Pathogenesis. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:685 / 692
页数:8
相关论文
共 50 条
  • [1] Molecular mechanisms in spinal muscular atrophy: models and perspectives
    Sendtner, M
    [J]. CURRENT OPINION IN NEUROLOGY, 2001, 14 (05) : 629 - 634
  • [2] Animal models of spinal muscular atrophy
    Frugier, T
    Cifuentes-Diaz, C
    Tiziano, F
    Miniou, P
    Roblot, N
    Joshi, V
    Melki, J
    [J]. NEUROMUSCULAR DISORDERS, 2001, 11 (6-7) : 642 - 642
  • [3] Animal models of spinal muscular atrophy
    Monani, UR
    Coovert, DD
    Burghes, AHM
    [J]. HUMAN MOLECULAR GENETICS, 2000, 9 (16) : 2451 - 2457
  • [4] Animal models of spinal muscular atrophy
    Schmid, Aloicia
    DiDonato, Christine J.
    [J]. JOURNAL OF CHILD NEUROLOGY, 2007, 22 (08) : 1004 - 1012
  • [5] Molecular mechanisms of spinal muscular atrophy
    Sumner, Charlotte J.
    [J]. JOURNAL OF CHILD NEUROLOGY, 2007, 22 (08) : 979 - 989
  • [6] Spinal Muscular Atrophy: Molecular Mechanisms
    Farrar, M. A.
    Johnston, H. M.
    Grattan-Smith, P.
    Turner, A.
    Kiernan, M. C.
    [J]. CURRENT MOLECULAR MEDICINE, 2009, 9 (07) : 851 - 862
  • [7] Molecular Mechanisms of Neurodegeneration in Spinal Muscular Atrophy
    Ahmad, Saif
    Bhatia, Kanchan
    Kannan, Annapoorna
    Gangwani, Laxman
    [J]. JOURNAL OF EXPERIMENTAL NEUROSCIENCE, 2016, 10 : 39 - 49
  • [8] Synaptic defects in spinal muscular atrophy animal models
    Torres-Benito, Laura
    Ruiz, Rocio
    Tabares, Lucia
    [J]. DEVELOPMENTAL NEUROBIOLOGY, 2012, 72 (01) : 126 - 133
  • [9] Dysregulation of innate immune signaling in animal models of spinal muscular atrophy
    Garcia, Eric L.
    Steiner, Rebecca E.
    Raimer, Amanda C.
    Herring, Laura E.
    Matera, A. Gregory
    Spring, Ashlyn M.
    [J]. BMC BIOLOGY, 2024, 22 (01)
  • [10] Pathogenesis, animal models and therapeutics in Spinal and bulbar muscular atrophy (SBMA)
    Katsuno, Masahisa
    Adachi, Hiroaki
    Waza, Masahiro
    Banno, Haruhiko
    Suzuki, Keisuke
    Tanaka, Fumiaki
    Doyu, Manabu
    Sobue, Gen
    [J]. EXPERIMENTAL NEUROLOGY, 2006, 200 (01) : 8 - 18